• OPEN AN ACCOUNT
Indian Indices
Sensex
78,542.44 43.27
( 0.06%)
Global Indices
Nasdaq
54,056.75 150.65
(0.28%)
Dow Jones
7,778.11 47.15
(0.61%)
Hang Seng
66,870.65 1,263.94
(1.93%)
Nikkei 225
10,869.98 -31.11
(-0.29%)
Forex
USD-INR
95.20 0.13
(0.14%)
EUR-INR
109.83 0.08
(0.08%)
GBP-INR
128.13 0.14
(0.11%)
JPY-INR
0.60 0.00
(-0.12%)

EQUITY - MARKET SCREENER

Lyka Labs Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500259
INE933A01014
24.1923243
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
LYKALABS
0
244.46
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

Lyka Labs reports consolidated net loss of Rs 7.61 crore in the March 2026 quarter
May 25,2026
Net loss of Lyka Labs reported to Rs 7.61 crore in the quarter ended March 2026 as against net profit of Rs 1.77 crore during the previous quarter ended March 2025. Sales declined 16.15% to Rs 28.03 crore in the quarter ended March 2026 as against Rs 33.43 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 10.03 crore in the year ended March 2026 as against net profit of Rs 8.01 crore during the previous year ended March 2025. Sales declined 7.26% to Rs 128.44 crore in the year ended March 2026 as against Rs 138.50 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales28.0333.43 -16 128.44138.50 -7
OPM %-23.0112.20 --2.8512.95 -
PBDT-6.544.43 PL -3.3217.89 PL
PBT-8.593.02 PL -11.7811.12 PL
NP-7.611.77 PL -10.038.01 PL